OCTOBER 31, 2012 – More than half of patients who undergo surgical treatment for hidradenitis suppurativa experience one or more indicators of unmet treatment needs – in other words, a suboptimal result – during the subsequent 12 months, according to Dr. Gregor B. Jemec of the University of Copenhagen.
“Very often hidradenitis suppurativa is considered a disease that is treatable only surgically. This study highlights the need for development of effective nonsurgical treatment options for people with hidradenitis suppurativa,” he said at the annual congress of the European Academy of Dermatology and Venereology.
Dr. Jemec presented a retrospective claims-based analysis of the economic burden of failed HS surgery in the United States.
He and his coinvestigators identified 2,668 patients in the Ingenix Employer Solutions database who underwent surgery for HS within 6 months after being diagnosed with the skin disease. The researchers came up with a list of indicators of unmet needs following surgery: development of surgical complications such as scarring, abscess, fistulization, or septicemia; an inpatient stay, office visit, or emergency department visit for HS; or another HS skin surgery. The investigators asked two questions: How many patients experienced one or more of these adverse outcome indicators within 12 months following surgery, and what was the associated economic cost?
READ THE FULL ARTICLE HERE: Surgery for Hidradenitis Suppurativa: Results Mostly Suboptimal : Dermatology NewsTags: Dermatology Specialist Treatment